Drug Interactions between Copper and penicillamine
This report displays the potential drug interactions for the following 2 drugs:
- Copper (copper gluconate)
- penicillamine
Interactions between your drugs
penicillAMINE copper gluconate
Applies to: penicillamine and Copper (copper gluconate)
PenicillAMINE and copper gluconate should not be taken orally at the same time. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of penicillAMINE into the bloodstream and reduce its effectiveness. You should take copper gluconate at least 2 hours before or 2 hours after the penicillAMINE dose, penicillAMINE should be taken at least 2 hours before and not less than 6 hours after Suprep Bowel Prep (magnesium/potassium/sodium sulfates), or penicillAMINE and copper gluconate should be taken as directed by your healthcare provider. Talk to your healthcare provider if you are unsure whether your medications contain something that could potentially interact or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
penicillAMINE food/lifestyle
Applies to: penicillamine
You may experience reduced absorption of penicillAMINE in the presence of food. The effectiveness of the antibiotic may be reduced. PenicillAMINE should be administered one hour before or two hours after meals and at least one hour apart from any other drug, food, or milk. This will make it easier for your body to absorb the medication.
penicillAMINE food/lifestyle
Applies to: penicillamine
PenicillAMINE and multivitamin with minerals should not be taken orally at the same time. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of penicillAMINE into the bloodstream and reduce its effectiveness. You should take multivitamin with minerals at least 2 hours before or 2 hours after the penicillAMINE dose, penicillAMINE should be taken at least 2 hours before and not less than 6 hours after Suprep Bowel Prep (magnesium/potassium/sodium sulfates), or penicillAMINE and multivitamin with minerals should be taken as directed by your healthcare provider. Talk to your healthcare provider if you are unsure whether your medications contain something that could potentially interact or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Disease interactions
penicillAMINE Bone Marrow Depression/Low Blood Counts
Applies to: Bone Marrow Depression/Low Blood Counts
The use of penicillamine is contraindicated in patients with a history of penicillamine-related aplastic anemia or agranulocytosis.
penicillAMINE Renal Dysfunction
Applies to: Renal Dysfunction
Penicillamine is considerably excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. The use of penicillamine is contraindicated in patients with renal dysfunction. Proteinuria and/or hematuria may develop during therapy and may lead to nephrotic syndrome. Monitoring for proteinuria and hematuria is recommended. Caution should be taken and routine monitoring of renal function is recommended.
penicillAMINE Allergies
Applies to: Allergies
Penicillin products should be used with caution in individuals with histories of significant allergies and/or asthma.
penicillAMINE Asthma
Applies to: Asthma
Penicillin products should be used with caution in individuals with histories of significant allergies and/or asthma.
copper gluconate Biliary Obstruction
Applies to: Biliary Obstruction
The trace elements, copper and manganese, are excreted in the bile. Copper and manganese doses may need to be adjusted, reduced, or omitted in patients with liver disease or biliary obstruction.
penicillAMINE Cholelithiasis
Applies to: Cholelithiasis
Cases of intrahepatic cholestasis and toxic hepatitis have been reported with the use of penicillamine. Care should be taken and liver function tests are recommended every six months for the duration of therapy.
penicillAMINE Goodpasture's Syndrome
Applies to: Goodpasture's Syndrome
The use of penicillamine has been associated with fatalities due to certain diseases such as Goodpasture's syndrome, and myasthenia gravis. Caution is advised in patients with these conditions.
penicillAMINE Liver Disease
Applies to: Liver Disease
Cases of intrahepatic cholestasis and toxic hepatitis have been reported with the use of penicillamine. Care should be taken and liver function tests are recommended every six months for the duration of therapy.
copper gluconate Liver Disease
Applies to: Liver Disease
The trace elements, copper and manganese, are excreted in the bile. Copper and manganese doses may need to be adjusted, reduced, or omitted in patients with liver disease or biliary obstruction.
copper gluconate Malabsorption Syndrome
Applies to: Malabsorption Syndrome
The trace metals manganese, chromium, copper, selenium, and zinc are absorbed in the GI tract from dietary sources and following administration of oral supplements. GI absorption may be decreased in patients with malabsorption syndromes. Therefore, larger dosages may be required when these supplements are given orally. Parenteral administration may be appropriate.
penicillAMINE Myasthenia Gravis
Applies to: Myasthenia Gravis
The use of penicillamine has been associated with fatalities due to certain diseases such as Goodpasture's syndrome, and myasthenia gravis. Caution is advised in patients with these conditions.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.